Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2011

Open Access 01-12-2011 | Oral presentation

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?

Authors: Kathleen A Boyd, Andrew H Briggs, Jim Paul, Tim Iveson, Rachel Midgely, Andrea Harkin, Gaynor Bates, Laura Alexander, Jim Cassidy

Published in: Trials | Special Issue 1/2011

Login to get access

Excerpt

The SCOT colorectal cancer trial is a phase III randomised controlled, multi-centre, non-inferiority trial comparing the efficacy of 12 weeks of chemotherapy versus 24 weeks and the associated toxicity, along with a lifetime economic analysis. The economic analysis will use prospective trial data to inform a lifetime cost-effectiveness model. …
Metadata
Title
Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
Authors
Kathleen A Boyd
Andrew H Briggs
Jim Paul
Tim Iveson
Rachel Midgely
Andrea Harkin
Gaynor Bates
Laura Alexander
Jim Cassidy
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue Special Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-S1-A41

Other articles of this Special Issue 1/2011

Trials 1/2011 Go to the issue

Oral presentation

Data modeling methods in clinical trials: experiences from the clinical trial methods in neurodegenerative diseases project

Oral presentation

A practical solution to ‘Continuing Care Site’ issues in neonatal clinical trials – a pragmatic approach to regulatory and research governance review

Oral presentation

Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report

Poster presentation

Optimising patient recall of adverse events over prolonged time periods

Oral presentation

Is there a danger of “biocreep” with non-inferiority trials?

Poster presentation

Recruiting patients cost-effectively by mail